ZhuZhou QianJin Pharmaceutical Co.,Ltd

Equities

600479

CNE000001GX3

Pharmaceuticals

End-of-day quote Shanghai S.E. 06:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
11.46 CNY -0.61% Intraday chart for ZhuZhou QianJin Pharmaceutical Co.,Ltd +2.69% +6.41%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Qianjin Pharma Unit Gets Nod for Supplemental New Drug Application for Teralithe Biosimilar MT
ZhuZhou QianJin Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Hunan Xinhexin Bio-Pharmaceutical Co., Ltd. announced that it has received CNY 50 million in funding from a group of investors CI
Hunan Xinhexin Bio-Pharmaceutical Co., Ltd. announces tranche update CI
Hunan Xinhexin Bio-Pharmaceutical Co., Ltd. announced that it expects to receive CNY 310 million in funding from ZhuZhou QianJin Pharmaceutical Co.,Ltd, Capstone Strategic, Inc. CI
ZhuZhou QianJin Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Hunan Xinhexin Bio-Pharmaceutical Co., Ltd. announced that it expects to receive CNY 500 million in funding from ZhuZhou QianJin Pharmaceutical Co.,Ltd CI
ZhuZhou QianJin Pharma Gets Nod to Register Blood Circulation Drug in Canada MT
QianJin Pharma’s Product Selected Among Top 100 Evidenced-Based Traditional Chinese Medicines MT
ZhuZhou QianJin Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
ZhuZhou QianJin Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
ZhuZhou QianJin Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Zhuzhou Qianjin Pharma's Unit Gets Nod for Chronic Hepatitis B Drug MT
ZhuZhou QianJin Pharma Promotes Vice Chairman to Chairman MT
Zhuzhou QianJin Pharmaceutical's Chairman Resigns; Shares Rose 5% MT
ZhuZhou QianJin Pharma Appoints Vice Chairman MT
ZhuZhou QianJin Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
ZhuZhou QianJin Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022 CI
ZhuZhou QianJin Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
ZhuZhou QianJin Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021 CI
ZhuZhou QianJin Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Zhuzhou Qianjin Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Zhuzhou Qianjin Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Zhuzhou Qianjin Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Zhuzhou Qianjin Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2020 CI
Chart ZhuZhou QianJin Pharmaceutical Co.,Ltd
More charts
ZhuZhou QianJin Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research and development, production, wholesaling and retailing of drugs. The Company's main products include tablets, granules, pills, hard capsules, syrups, herbs, vinum and gels, among others. The company is also involved in the businesses of cultural entertainment, logistics and distribution, as well as the provision of hygienic products.
Calendar
More about the company